Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
The Oncologist
|
September 7, 1999
Race, ethnicity, and the patient-caregiver relationship
J Dedier, R Penson, W Williams, et al.
International Journal of STD & AIDS
|
August 1, 1997
Metastatic tufted angioma
R Penson, C Gallagher, Y Hooi, et al.
Anticancer Research
|
February 24, 2001
TRAG-3, a novel cancer/testis antigen, is overexpressed in the majority of melanoma cell lines and malignant melanoma
A J Feller, Z Duan, R Penson, et al.
Gynecologic Oncology
|
March 31, 2000
Efficacy and hematologic toxicity of salvage chemotherapy following stem cell-supported high-dose chemotherapy in women with recurrent ovarian cancer
S Cook, R Penson, L Duska, et al.
British Journal of Cancer
|
January 1, 1997
Continuous infusional topotecan in advanced breast and non-small-cell lung cancer: no evidence of increased efficacy
P N Mainwaring, M C Nicolson, T Hickish, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 23, 1998
A randomised, concentration-controlled, comparison of standard (5-day) vs. prolonged (15-day) infusions of etoposide phosphate in small-cell lung cancer
S Joel, K O'Byrne, R Penson, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 26, 2008
Long-term adjustment of early-stage ovarian cancer survivors
U A Matulonis, A Kornblith, H Lee, et al.
British Journal of Cancer
|
January 1, 1997
Single-agent paclitaxel in patients with previously untreated stage IV epithelial ovarian cancer. London Gynaecological Oncology and North Thames Gynaecological Oncology Groups
M E Gore, G Rustin, M Slevin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 2, 1999
A Phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancer
L R Duska, R Penson, J G Supko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1996
Therapeutic monitoring of continuous infusion etoposide in small-cell lung cancer
S P Joel, P Ellis, K O'Byrne, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
The Oncologist
|
September 7, 1999
Race, ethnicity, and the patient-caregiver relationship
J Dedier, R Penson, W Williams, et al.
International Journal of STD & AIDS
|
August 1, 1997
Metastatic tufted angioma
R Penson, C Gallagher, Y Hooi, et al.
Anticancer Research
|
February 24, 2001
TRAG-3, a novel cancer/testis antigen, is overexpressed in the majority of melanoma cell lines and malignant melanoma
A J Feller, Z Duan, R Penson, et al.
Gynecologic Oncology
|
March 31, 2000
Efficacy and hematologic toxicity of salvage chemotherapy following stem cell-supported high-dose chemotherapy in women with recurrent ovarian cancer
S Cook, R Penson, L Duska, et al.
British Journal of Cancer
|
January 1, 1997
Continuous infusional topotecan in advanced breast and non-small-cell lung cancer: no evidence of increased efficacy
P N Mainwaring, M C Nicolson, T Hickish, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 23, 1998
A randomised, concentration-controlled, comparison of standard (5-day) vs. prolonged (15-day) infusions of etoposide phosphate in small-cell lung cancer
S Joel, K O'Byrne, R Penson, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 26, 2008
Long-term adjustment of early-stage ovarian cancer survivors
U A Matulonis, A Kornblith, H Lee, et al.
British Journal of Cancer
|
January 1, 1997
Single-agent paclitaxel in patients with previously untreated stage IV epithelial ovarian cancer. London Gynaecological Oncology and North Thames Gynaecological Oncology Groups
M E Gore, G Rustin, M Slevin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 2, 1999
A Phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancer
L R Duska, R Penson, J G Supko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1996
Therapeutic monitoring of continuous infusion etoposide in small-cell lung cancer
S P Joel, P Ellis, K O'Byrne, et al.
Page
of 1